Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 24;10(13):e31723.
doi: 10.1016/j.heliyon.2024.e31723. eCollection 2024 Jul 15.

The interrelation of scientific, ethical, and translational challenges for precision medicine with multimodal biomarkers - A qualitative expert interview study in dermatology research

Affiliations

The interrelation of scientific, ethical, and translational challenges for precision medicine with multimodal biomarkers - A qualitative expert interview study in dermatology research

Nora Hangel et al. Heliyon. .

Abstract

This qualitative study examines the impact of scientific, ethical, and translational challenges of precision medicine for atopic dermatitis and psoriasis. The study explores how these challenges affect biomarker research for inflammatory skin diseases as identified by stakeholders, including patient board representatives, pharmaceutical industry partners, and postdoctoral and senior researchers from multiple disciplines in biomarker research. We recruited participating experts both within and associated with the international Biomarkers in Atopic Dermatitis and Psoriasis (BIOMAP) consortium to ensure representation of the different organizational units of the consortium. For the study, we followed the COREQ checklist. The interviews were conducted using GDPR-safe online platforms and the pseudonymized transcripts were analyzed using Atlas.ti. We analyzed the interviews from participants' personal experiences, topic-oriented, and group specific to identify the main themes presented in this article. The findings were presented to peers and to the wider BIOMAP audience, discussed, and a draft was circulated within the consortium for feedback. In this study, we identify and discuss the interrelation of challenges that are relevant to improving precision medicine with multimodal biomarkers. We show how scientific challenges can interrelate with ethical and translational issues, and explain these interdependencies and articulate epistemic and social factors of interdisciplinary collaboration. Based on our findings, we suggest that including patient representatives' perspectives is crucial for highly interrelated and widely diverse research. The proposed integrative perspective is beneficial for all involved stakeholders. Effective communication of science requires reflection on the tension between scientific uncertainty and the goals of precision medicine. Furthermore, we show how changing the perception of the diseases, atopic dermatitis, and psoriasis can benefit patients beyond medical practice.

Keywords: Biomarker; Biomedical research; Ethics; Interview study; Physician-patient relations; Translational research.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Setup and workflow of the consortium. The graphic depicts the tight interaction between the individual work packages and relates to the major aims. ©Biomap consortium.
Fig. 2
Fig. 2
Interrelations of scientific, ethical and translational challenges in biomarker research/application for AD/Pso.

Similar articles

Cited by

References

    1. Armstrong A.W., Read C. Pathophysiology, clinical presentation, and treatment of psoriasis A review. JAMA, J. Am. Med. Assoc. 2020;323(19):1945–1960. - PubMed
    1. Bylund S., et al. Prevalence and incidence of atopic dermatitis: a systematic review. Acta DV Advances in dermatology and venereology. 2020;100 - PMC - PubMed
    1. Karimkhani C., et al. Global skin disease morbidity and mortality: an update from the global burden of disease study 2013. JAMA Dermatol. 2017;153(5):406–412. - PMC - PubMed
    1. Langley R.G.B. Psoriasis: epidemiology, clinical features, and quality of life. Ann. Rheum. Dis. 2005;64(suppl_2):ii18–ii23. - PMC - PubMed
    1. Chovatiya R., Silverberg J.I. Pathophysiology of atopic dermatitis and psoriasis: implications for management in children. Children. 2019;6(10) - PMC - PubMed

LinkOut - more resources